Investors

Investors

Overview

Medicure was founded in 1997 and became a public company in November 1999. The company trades under the symbol MPH on the TSX Venture Exchange. As a U.S focused Specialty Pharma company with established sales of Aggrastat, Medicure carefully monitors opportunities within its own pipeline of products and possible acquisitions of related pharma companies in order to realize long term value.

Corporate Presentation

Investor Presentation

Conference Call

Financial Reports

Quarterly and Annual financial reports will be posted below after release.

Effective Dec 18, 2014 the Fiscal Year End was changed to December 31 from May 31.

Edgar and SEDAR filings for Medicure can be found on their respected websites.

Financial Reports for 2018

Q2 - June 30, 2018

Q1 - March 31, 2018

Financial Reports for 2017

Q4 - December 31, 2017

Q3 - Septemeber 30, 2017

Q2 - June 30, 2017

Q1 - March 31, 2017

Financial Reports for 2016

Q4 and Year End - April 26, 2017

Q3 - September 30, 2016

Q2 - June 30, 2016

Q1 - March 31, 2016

Financial Reports for 2015

Q4 and Year End - December 31, 2015

Q3 - September 30, 2015

Q2 - June 30, 2015

Q1 - March 31, 2015

Financial Reports for 2014

7 Months Ended Dec 31, 2014

Q1 - Aug 31, 2014

Fiscal 2014 - May 31, 2014

Q3 - Feb 28, 2014

Financial Reports for 2013

Q2 - Nov 30, 2013

Q1 - Aug 31, 2013

Fiscal 2013 - May 31, 2013

Q3 - Feb 28, 2013

Financial Reports for 2012

Q2 - Nov 30, 2012

Q1 - Aug 31, 2012

Fiscal 2012 - May 31, 2012

Q3 - Feb 29, 2012

Financial Reports for 2011

Q2 - Nov 30, 2011

Q1 - Aug 31, 2011

Fiscal 2011 - May 31, 2011

Q3 - Feb 28, 2011